Neurofibromatosis type 1 (NF1) is the most common of the three types of neurofibromatosis and is also one of the most common inherited neurological disorders, affecting about 1 in 3,000 people ...

Oliver Bromley, a 42-year-old United Kingdom native, has numerous tumors on his face and body from Neurofibromatosis Type 1. The condition causes the benign growths to appear on nerve endings.

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...

Neurofibromatosis type 1 (NF1), specifically ... rather than these physical signs are the difficulties the patients may face depending on the part of the body affected by the condition.

The FDA recently approved mirdametinib (Gomekli; SpringWorks Therapeutics) to treat adults and children aged 2 and older with neurofibromatosis type 1 (NF1 ... on the face, the neck, or visible ...

Reivi Dela Cruz was only four years old when he was diagnosed with Neurofibromatosis Type 1 (NF1), a genetic condition that causes tumors (neurofibromas, which are usually non-cancerous) to grow on or ...

Open-label, Phase 2 Clinical Trial of Crizotinib for Children and Adults with Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas Crizotinib (Xalkori®), a small molecule kinase inhibitor, ...

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I ...